QA: Arqule INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001019695_2015_Arqule_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001019695, Arqule INC

  xvar xval
0 AssetsCurrent 61,101,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 133,000
3 remainder_Assets 2,160,000
4 LiabilitiesCurrent 18,277,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 4,572,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,128,003
9 ResearchAndDevelopmentExpense 23,074,442
10 remainder_Expenses 1,981,587
11 remainder_Revenues 3,567,000
12 remainder_NetIncome 11,833,992
13 remainder_ComprehensiveNetIncome -67,439
  yvar yval
0 Assets 63,394,000
1 Liabilities 22,849,000
2 Expenses 37,184,032
3 Revenues 3,567,000
4 StockholdersEquity 40,545,000
5 NetIncome -21,783,040
6 ComprehensiveNetIncome -21,816,760
7 BaseVar 69,447,732
8 EconomicCapitalRatiobeforeLimitedLiability 1.54
9 EconomicCapitalRatio 2.71

Edgar->Model Mapping

Feature Distribution

Change over Time